Physician profile
Robert Howard Patton
NPI 1689659195
$7,789.44
in general payments reported to CMS, 2019-2025
41 companies · $907 in 2025
The $907 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,048 · 2020: $258 · 2021: $914 · 2022: $1,411 · 2023: $1,778 · 2024: $1,473 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,157.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,402.00 | 2019-2025 | |
| Amgen INC. | $961.47 | 2019-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $785.43 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $728.10 | 2019-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $579.82 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $476.37 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $383.86 | 2021-2023 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $322.82 | 2022-2025 | |
| Pfizer INC. | $316.59 | 2019-2025 | |
| Mylan Specialty L.P. | $212.90 | 2021-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $177.67 | 2019-2022 | |
| Dexcom, INC. | $133.58 | 2021-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $121.78 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $111.62 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $105.89 | 2021-2025 | Eliquis |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.